ABBV Competitors
AbbVie Inc.
$292.09
-$1.22(-0.41%)
58
Overall
60
Value
66
Tech
50
Quality
Market Cap
$516.29B
Volume
999.01K
52W Range
$190.75 - $302.93
Target Price
$305.93
ABBV competitors: PFE, BMY, LLY, AMGN, GILD. AbbVie Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
ABBV Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| PFE Pfizer Inc. | $29.23 | $167.52B | $3.04 | 4.41% | 74 |
| BMY Bristol-Myers Squibb Company | $62.14 | $127.02B | $6.43 | 4.06% | 69 |
| LLY Eli Lilly and Company | $1411.95 | $1.27T | $35.35 | 0.47% | 69 |
| AMGN Amgen Inc. | $465.23 | $249.05B | $23.51 | 2.14% | 66 |
| GILD Gilead Sciences, Inc. | $169.32 | $207.00B | $-0.98 | 1.92% | 68 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABBV | $292.09 | -0.4% | 999.01K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |